Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeutic is a research paper published in Immunotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Intramural Research Program of the Center for Cancer Research, National Cancer Institute
Grant: ZIA BC 009283
Secretaria de Ciencia y Tecnología-UNC
Grant: 2018-2021
Fundación para el Progreso de la Medicina
Grant: GC N°1
FWCI
0.22
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Supplementary Figures 1–6: Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeutic
Supplementary Figures 7–11: Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeutic
Supplementary Figures 7–11: Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeutic
Supplementary Figures 1–6: Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeutic